Smoking and lipoprotein abnormalities on platelet aggregation in coronary heart disease

International Journal of Cardiology

Volumn 62, Issue 2, 1997, Pages 151-154

  De Padua Mansur, Antonio ^a   Caramelli, Bruno ^a   Vianna, Caio Brito ^a   Chamone, Dalton ^a   Ramires, José Antonio F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coronary disease; Dyslipidemia; Platelet aggregability; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; DYSLIPIDEMIA; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BLOOD PLATELET DISORDERS; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SMOKING;

EID: 0031470023     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00203-9     Document Type: Article

References (30)

1. Austin M.R. Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol. 129:1989;249-259.
2. Thaulow E., Erikssen J., Sandvik L., Stormorken H., Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 84:1991;613-617.
3. Hung J., Lam J.Y., Lacoste L., Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation. 92:1995;2432-2436.
4. Meade T.W., Vickers M.V., Thompson S.G., Stirling Y., Haines A.P., Miller G.J. Epidemiological characteristics of platelet aggregability. Br Med J. 290:1985;428-432.
5. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-1445.
6. Röschlau P., Bernt E., Gruber W. Enzymatische Bestimmung des Gesamt-cholesterins im Serum. Klin Chem Klin Biochem. 12:1974;403-407.
7. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476-482.
8. Warnick G.R., Benderson J.M., Albers J.J. Dextran sulfate precipitation procedure for quantification of high density lipoprotein. Clin Chem. 28:1982;1379-1388.
9. Freidwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
10. Born G.V.R., Cross M.J. The aggregation of blood platelets. J Physiol. 168:1963;178-195.
11. Brecher G., Cronkite E.P. Morphology and enumeration of human blood platelets. J Apply Physiol. 3:1950;365-377.
12. Kugiyama K., Kerns S.A., Morrissett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160-162.
13. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W.et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New Engl J Med. 315:1986;1046-1051.
14. Yamamoto H., Bossaller C., Cartwright J. Jr., Henry P.D. Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest. 81:1988;1752-1758.
15. Ware J.A., Heistad D.D. Platelet-endothelium interactions. New Engl J Med. 328:1993;628-635.
16. Nowak J., Murray J.J., Oates J.A., FitzGerald G.A. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation. 76:1987;6-14.
17. Meade T.W., Imeson J., Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet. 2:1987;986-988.
18. Miller G.J., Martin J.C., Webster J., Wilkes H., Miller N.E., Wilkinson W.H.et al. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Atherosclerosis. 60:1986;269-277.
19. Folsom A.R., Wu K.K., Davis C.E., Conlan M.G., Sorlie P.D., Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 91:1991;191-205.
20. Hamsten A., Wimen B., de Faire U., Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New Engl J Med. 313:1985;1557-1563.
21. Morrow J.D., Frei B., Longmire A.W.et al. Increase in circulating products of lipid peroxidation (F2-Isoprostanes) in smokers. Smoking as a cause of oxidative damage. New Engl J Med. 332:1995;1198-1203.
22. Sanderson K.J., van Rij A.M., Wade C.R., Sutherland W.H.F. Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis. 118:1995;45-51.
23. Mussoni L., Mannucci L., Sirtori M., Camera M., Maderna P., Sironi L.et al. Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb. 12:1992;19-25.
24. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoproteins AI. Nature. 353:1991;265-267.
25. Badimon J.J., Badimon L., Galvez A., Dische R., Fuster V. High-density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest. 60:1989;455-461.
26. Badimon J.J., Badimon L., Fuster V. Regression of atherosclerotic lesions by high-density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 85:1990;1234-1241.
27. Fleisher L.N., Tall A.R., Witte L.D., Miller R.W., Cannon P.J. Stimulation of arterial endothelial cell prostacyclin synthesis by high-density lipoproteins. J Biol Chem. 257:1982;6653-6655.
28. Aoyama T., Yui Y., Morishita H., Kawai C. Prostaglandin I2 half-life regulated by high-density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris. Circulation. 81:1990;1784-1791.
29. Saku K., Ahmad M., Glas-Greenwalt P., Kashyap M.I. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Thromb Res. 39:1985;1-8.
30. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.